Q1 2021 13F Holders as of 3/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
233
-
Total 13F shares, excl. options
-
98.8M
-
Shares change
-
-141K
-
Total reported value, excl. options
-
$4.76B
-
Value change
-
-$16.9M
-
Put/Call ratio
-
1.38
-
Number of buys
-
120
-
Number of sells
-
-121
-
Price
-
$48.20
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q1 2021
302 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q1 2021.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 233 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 98.8M shares
of 157M outstanding shares and own 62.81% of the company stock.
Largest 10 shareholders include FMR LLC (18M shares), VANGUARD GROUP INC (11.1M shares), BlackRock Inc. (9.3M shares), LORD, ABBETT & CO. LLC (4.7M shares), RA CAPITAL MANAGEMENT, L.P. (4.64M shares), WELLINGTON MANAGEMENT GROUP LLP (4.32M shares), ALKEON CAPITAL MANAGEMENT LLC (4.09M shares), STATE STREET CORP (3.26M shares), Capital World Investors (3.15M shares), and MAVERICK CAPITAL LTD (2.97M shares).
This table shows the top 233 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.